Insider buying last 90 days
$64Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 17 | Chuck Kyrish SVP & CFO | Purchase | $64K |
From Form 4 filings, dated to when each was filed.
Celanese posted Q3 2026 results this week, topping EPS estimates by $0.09 with earnings of $1.65, though revenue of $2.56 billion fell slightly short of consensus. Management offered FY2026 EPS guidance of $6.00-$6.25, aligning with analyst expectations. The stock nonetheless underperformed peers on both Wednesday and Friday sessions despite broader market gains, closing lower each time. Separately, the company announced polyamide and polyester price increases in Asia and a partnership with Rochling to expand lower-carbon POM applications using carbon capture technology.
Shares closed at $48.75, up 4.9%, sitting between the 50-day moving average of $46.43 and the 200-day average of $51.64, reflecting a mixed trend picture. The GekkoIndex reads 56.3, placing CE in the Neutral zone, up 6.4 over five days. The stock trades 43% below Gekko Fair Value of $85.56, a gap that stands out against the one-year return of 35% and a six-month decline of 18.1%.
The next earnings date falls on 16 February 2027, 98 days out and beyond a typical 20-trading-day hold. Over the last 90 days, two open-market insider purchases totaling $161,746 have been recorded, alongside one trailblazer holder. Eleven analysts cover the stock, with 6 rating it buy and 5 hold, and a consensus target of $62.50 implying 28.2% upside. Seasonality over the next 20 trading days has averaged 0.1% across 5 years, rising in 2 of them, a historically modest and mixed pattern worth noting.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Celanese scores 4 supportive, 2 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive2 mixed0 headwinds
Averages disagree
Close $51.41 sits between the 50-day ($46.86) and 200-day ($51.73) averages, or the averages disagree.
See the chart51.1, Neutral
Reading 51.1 is in the Neutral zone.
See the GekkoIndex42.4% below
Price is 42.4% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 1 open-market insider purchase.
See smart moneyReports in 93 days
Next report Feb 16, 2027, 93 days away — outside a typical 20-trading-day hold.
See earnings+3.3% on average
From this point in the calendar, the next 20 trading days averaged +3.3% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Celanese closed at $51.41 on Nov 13, 2026, +31.4% over the past year, inside a 52-week range of $35.13 to $70.70.
Use the left and right arrow keys to read daily values.
Put CE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Celanese develops and supplies a broad range of specialty polymers to manufacturers around the globe. Its materials span elastomers, copolymers, liquid crystal polymers, reinforced plastics, and nylon or polypropylene formulations, which end up inside appliances, vehicles, buildings, clothing, gadgets, energy storage systems, filtration gear, medical tools and communications hardware. Many of these offerings carry long-established brand names that customers in these industries would recognize.
Internally, the business runs through two segments: Engineered Materials and Acetyl Chain. The Acetyl Chain unit turns out acetic acid, anhydride, acetate tow and flake, vinyl acetate monomers, emulsion polymers and formaldehyde-based chemicals, which get used in adhesives, paints, coatings, packaging, textiles, pharmaceuticals and building products like insulation and renders. Celanese moves its goods to market through a mix of direct sales, distributor networks, and relationships with equipment makers and suppliers.
The company dates back to 1912 and keeps its headquarters in Irving, Texas. Investors can find its stock listed on the NYSE under the ticker CE.
Celanese’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.1, in the Neutral zone, down 7.4 points over five sessions.
Down 7.4 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 61 | +0.4% | +1.5% | ||
| Accumulation | 284 | −1.1% | −2.7% | ||
| Neutral (current zone) | 342 | −0.1% | −2.5% | ||
| Distribution | 14 | −0.9% | +3.2% | ||
| Selling | 1 | Too few readings yet | |||
Average CE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Celanese trades 42.4% below Gekko Fair Value of $89.30, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Celanese shares are worth, recalculated every trading day.
$89.30
Gekko Fair Value, Nov 14, 2026
42.4% Undervalued
At the end of Aug 2026 the price was 20.8% below the estimate.
Insiders filed 1 open-market purchase in Celanese worth $64K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$64Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 17 | Chuck Kyrish SVP & CFO | Purchase | $64K |
From Form 4 filings, dated to when each was filed.
No trades in CE were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Celanese has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds CE.
Celanese reports on Feb 16, 2027 (93 days away), and beat the EPS estimate in 5 of its last 8 reports.
Feb 16, 2027
93 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $2.45 est $2.21 | $2.75B est $2.75B | −1.7% |
| May 5, 2026 | $0.85 est $0.90 | $2.34B est $2.34B | −9.6% |
| Feb 17, 2026 | $0.67 est $0.91 | $2.20B est $2.25B | −6.8% |
| Nov 6, 2025 | $1.34 est $1.27 | $2.42B est $2.25B | +11.8% |
| Aug 11, 2025 | $1.44 est $1.38 | $2.53B est $2.55B | −14.2% |
| May 5, 2025 | $0.57 est $0.37 | $2.39B est $2.46B | +6.7% |
| Feb 18, 2025 | $1.45 est $1.25 | $2.37B est $2.36B | −19.3% |
| Nov 4, 2024 | $2.44 est $2.85 | $2.65B est $2.70B | −27.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Celanese is $63.39, +23.3% from the last close, from 12 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 12 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 10 | UBS | $58 | +12.8% |
| Nov 9 | Morgan Stanley | $58 | +12.8% |
| Nov 9 | BMO Capital | $58 | +12.8% |
| Nov 9 | KeyBanc | $59 | +14.8% |
| Nov 9 | KeyBanc | $59 | +14.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Celanese averaged +3.3% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.3% | 1 of 5 |
| Next 10 trading days | +1.2% | 3 of 5 |
| Next 15 trading days | +0.8% | 2 of 5 |
| Next 20 trading days | +3.3% | 3 of 5 |
| Next 30 trading days | +4.7% | 2 of 5 |
For scale, CE’s typical 20-trading-day move in either direction is about 7%.
Celanese’s market cap is $5.64B, with a P/E ratio of 20.8 and revenue of $9.85B over the last twelve months.
2 headlines about Celanese from the past week, newest first, each linking to the publisher.
Celanese’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LINLinde | Neutral | 4.8% above |
| ECLEcolab | Neutral | 16.6% above |
| APDAir Products and Chemicals | Neutral | 0.5% above |
| DOWDow | Neutral | 23.9% below |
| LYBLyondellBasell Industries | Neutral | 6.5% below |
| ALBAlbemarle | Accumulation | 20.7% below |
A peer links to its own page where one exists.
Celanese’s market cap is $5.64B at the Nov 13, 2026 close of $51.41, with 109.8M shares outstanding. The shares trade on a P/E ratio of 20.8.
The consensus analyst 12-month price target for Celanese is $63.39, +23.3% from the last close. Of the 12 firms that rated the stock in the last 90 days, 6 rate it a buy, 6 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Celanese is undervalued: the Nov 13, 2026 close of $51.41 is 42.4% below Gekko Fair Value of $89.30. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Celanese is expected to report on Feb 16, 2027 (93 days away). Analysts expect earnings of $1.17 per share on revenue of $2.34B. Celanese beat the earnings estimate in 5 of its last 8 reports, moving 12.1% on average across the report.
Celanese’s 52-week high is $70.70 and its 52-week low is $35.13; it closed at $51.41 on Nov 13, 2026, +31.4% over the past year. Over the last five years the shares peaked at $176.50 on Jan 5, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (fair value, smart money, earnings risk and seasonality), 2 as mixed (trend and gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.